Global Cholera Vaccines Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Cholera Vaccines market size was valued at USD 86 million in 2023 and is forecast to a readjusted size of USD 152.7 million by 2030 with a CAGR of 8.6% during review period.
Cholera vaccines are vaccines that are effective at preventing cholera. For the first six months after vaccination they provide about 85 percent protection, which decreases to 50 percent or 62 percent during the first year.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Cholera Vaccines industry chain, the market status of Oral (Dukoral, Shanchol), Others (Dukoral, Shanchol), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cholera Vaccines.
Regionally, the report analyzes the Cholera Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cholera Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cholera Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cholera Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Dukoral, Shanchol).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cholera Vaccines market.
Regional Analysis: The report involves examining the Cholera Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cholera Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cholera Vaccines:
Company Analysis: Report covers individual Cholera Vaccines players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cholera Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oral, Others).
Technology Analysis: Report covers specific technologies relevant to Cholera Vaccines. It assesses the current state, advancements, and potential future developments in Cholera Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cholera Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cholera Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Cholera Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cholera Vaccines, with revenue, gross margin and global market share of Cholera Vaccines from 2019 to 2024.
Chapter 3, the Cholera Vaccines competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cholera Vaccines market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cholera Vaccines.
Chapter 13, to describe Cholera Vaccines research findings and conclusion.
Cholera vaccines are vaccines that are effective at preventing cholera. For the first six months after vaccination they provide about 85 percent protection, which decreases to 50 percent or 62 percent during the first year.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Cholera Vaccines industry chain, the market status of Oral (Dukoral, Shanchol), Others (Dukoral, Shanchol), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cholera Vaccines.
Regionally, the report analyzes the Cholera Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cholera Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cholera Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cholera Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Dukoral, Shanchol).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cholera Vaccines market.
Regional Analysis: The report involves examining the Cholera Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cholera Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cholera Vaccines:
Company Analysis: Report covers individual Cholera Vaccines players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cholera Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oral, Others).
Technology Analysis: Report covers specific technologies relevant to Cholera Vaccines. It assesses the current state, advancements, and potential future developments in Cholera Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cholera Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cholera Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Dukoral
- Shanchol
- Vaxchora
- Others
- Oral
- Others
- Shantha Biotechnics Private Limited
- PaxVax, Inc.
- Valneva SE
- Merck and Co., Inc.
- GlaxoSmithKline plc (GSK)
- Astellas Pharma, Inc.
- Pfizer, Inc.
- Emergent BioSolutions, Inc.
- Mitsubishi Tanabe Pharma Corporation
- Takeda Pharmaceutical Co., Ltd.
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Cholera Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cholera Vaccines, with revenue, gross margin and global market share of Cholera Vaccines from 2019 to 2024.
Chapter 3, the Cholera Vaccines competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cholera Vaccines market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cholera Vaccines.
Chapter 13, to describe Cholera Vaccines research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Cholera Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cholera Vaccines by Type
1.3.1 Overview: Global Cholera Vaccines Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Cholera Vaccines Consumption Value Market Share by Type in 2023
1.3.3 Dukoral
1.3.4 Shanchol
1.3.5 Vaxchora
1.3.6 Others
1.4 Global Cholera Vaccines Market by Application
1.4.1 Overview: Global Cholera Vaccines Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oral
1.4.3 Others
1.5 Global Cholera Vaccines Market Size & Forecast
1.6 Global Cholera Vaccines Market Size and Forecast by Region
1.6.1 Global Cholera Vaccines Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Cholera Vaccines Market Size by Region, (2019-2030)
1.6.3 North America Cholera Vaccines Market Size and Prospect (2019-2030)
1.6.4 Europe Cholera Vaccines Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Cholera Vaccines Market Size and Prospect (2019-2030)
1.6.6 South America Cholera Vaccines Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Cholera Vaccines Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Shantha Biotechnics Private Limited
2.1.1 Shantha Biotechnics Private Limited Details
2.1.2 Shantha Biotechnics Private Limited Major Business
2.1.3 Shantha Biotechnics Private Limited Cholera Vaccines Product and Solutions
2.1.4 Shantha Biotechnics Private Limited Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Shantha Biotechnics Private Limited Recent Developments and Future Plans
2.2 PaxVax, Inc.
2.2.1 PaxVax, Inc. Details
2.2.2 PaxVax, Inc. Major Business
2.2.3 PaxVax, Inc. Cholera Vaccines Product and Solutions
2.2.4 PaxVax, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 PaxVax, Inc. Recent Developments and Future Plans
2.3 Valneva SE
2.3.1 Valneva SE Details
2.3.2 Valneva SE Major Business
2.3.3 Valneva SE Cholera Vaccines Product and Solutions
2.3.4 Valneva SE Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Valneva SE Recent Developments and Future Plans
2.4 Merck and Co., Inc.
2.4.1 Merck and Co., Inc. Details
2.4.2 Merck and Co., Inc. Major Business
2.4.3 Merck and Co., Inc. Cholera Vaccines Product and Solutions
2.4.4 Merck and Co., Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Merck and Co., Inc. Recent Developments and Future Plans
2.5 GlaxoSmithKline plc (GSK)
2.5.1 GlaxoSmithKline plc (GSK) Details
2.5.2 GlaxoSmithKline plc (GSK) Major Business
2.5.3 GlaxoSmithKline plc (GSK) Cholera Vaccines Product and Solutions
2.5.4 GlaxoSmithKline plc (GSK) Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 GlaxoSmithKline plc (GSK) Recent Developments and Future Plans
2.6 Astellas Pharma, Inc.
2.6.1 Astellas Pharma, Inc. Details
2.6.2 Astellas Pharma, Inc. Major Business
2.6.3 Astellas Pharma, Inc. Cholera Vaccines Product and Solutions
2.6.4 Astellas Pharma, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Astellas Pharma, Inc. Recent Developments and Future Plans
2.7 Pfizer, Inc.
2.7.1 Pfizer, Inc. Details
2.7.2 Pfizer, Inc. Major Business
2.7.3 Pfizer, Inc. Cholera Vaccines Product and Solutions
2.7.4 Pfizer, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Pfizer, Inc. Recent Developments and Future Plans
2.8 Emergent BioSolutions, Inc.
2.8.1 Emergent BioSolutions, Inc. Details
2.8.2 Emergent BioSolutions, Inc. Major Business
2.8.3 Emergent BioSolutions, Inc. Cholera Vaccines Product and Solutions
2.8.4 Emergent BioSolutions, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Emergent BioSolutions, Inc. Recent Developments and Future Plans
2.9 Mitsubishi Tanabe Pharma Corporation
2.9.1 Mitsubishi Tanabe Pharma Corporation Details
2.9.2 Mitsubishi Tanabe Pharma Corporation Major Business
2.9.3 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product and Solutions
2.9.4 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Mitsubishi Tanabe Pharma Corporation Recent Developments and Future Plans
2.10 Takeda Pharmaceutical Co., Ltd.
2.10.1 Takeda Pharmaceutical Co., Ltd. Details
2.10.2 Takeda Pharmaceutical Co., Ltd. Major Business
2.10.3 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product and Solutions
2.10.4 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Takeda Pharmaceutical Co., Ltd. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cholera Vaccines Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Cholera Vaccines by Company Revenue
3.2.2 Top 3 Cholera Vaccines Players Market Share in 2023
3.2.3 Top 6 Cholera Vaccines Players Market Share in 2023
3.3 Cholera Vaccines Market: Overall Company Footprint Analysis
3.3.1 Cholera Vaccines Market: Region Footprint
3.3.2 Cholera Vaccines Market: Company Product Type Footprint
3.3.3 Cholera Vaccines Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cholera Vaccines Consumption Value and Market Share by Type (2019-2024)
4.2 Global Cholera Vaccines Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cholera Vaccines Consumption Value Market Share by Application (2019-2024)
5.2 Global Cholera Vaccines Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Cholera Vaccines Consumption Value by Type (2019-2030)
6.2 North America Cholera Vaccines Consumption Value by Application (2019-2030)
6.3 North America Cholera Vaccines Market Size by Country
6.3.1 North America Cholera Vaccines Consumption Value by Country (2019-2030)
6.3.2 United States Cholera Vaccines Market Size and Forecast (2019-2030)
6.3.3 Canada Cholera Vaccines Market Size and Forecast (2019-2030)
6.3.4 Mexico Cholera Vaccines Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Cholera Vaccines Consumption Value by Type (2019-2030)
7.2 Europe Cholera Vaccines Consumption Value by Application (2019-2030)
7.3 Europe Cholera Vaccines Market Size by Country
7.3.1 Europe Cholera Vaccines Consumption Value by Country (2019-2030)
7.3.2 Germany Cholera Vaccines Market Size and Forecast (2019-2030)
7.3.3 France Cholera Vaccines Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Cholera Vaccines Market Size and Forecast (2019-2030)
7.3.5 Russia Cholera Vaccines Market Size and Forecast (2019-2030)
7.3.6 Italy Cholera Vaccines Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cholera Vaccines Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Cholera Vaccines Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Cholera Vaccines Market Size by Region
8.3.1 Asia-Pacific Cholera Vaccines Consumption Value by Region (2019-2030)
8.3.2 China Cholera Vaccines Market Size and Forecast (2019-2030)
8.3.3 Japan Cholera Vaccines Market Size and Forecast (2019-2030)
8.3.4 South Korea Cholera Vaccines Market Size and Forecast (2019-2030)
8.3.5 India Cholera Vaccines Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Cholera Vaccines Market Size and Forecast (2019-2030)
8.3.7 Australia Cholera Vaccines Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Cholera Vaccines Consumption Value by Type (2019-2030)
9.2 South America Cholera Vaccines Consumption Value by Application (2019-2030)
9.3 South America Cholera Vaccines Market Size by Country
9.3.1 South America Cholera Vaccines Consumption Value by Country (2019-2030)
9.3.2 Brazil Cholera Vaccines Market Size and Forecast (2019-2030)
9.3.3 Argentina Cholera Vaccines Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cholera Vaccines Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Cholera Vaccines Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Cholera Vaccines Market Size by Country
10.3.1 Middle East & Africa Cholera Vaccines Consumption Value by Country (2019-2030)
10.3.2 Turkey Cholera Vaccines Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Cholera Vaccines Market Size and Forecast (2019-2030)
10.3.4 UAE Cholera Vaccines Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Cholera Vaccines Market Drivers
11.2 Cholera Vaccines Market Restraints
11.3 Cholera Vaccines Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Cholera Vaccines Industry Chain
12.2 Cholera Vaccines Upstream Analysis
12.3 Cholera Vaccines Midstream Analysis
12.4 Cholera Vaccines Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Cholera Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cholera Vaccines by Type
1.3.1 Overview: Global Cholera Vaccines Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Cholera Vaccines Consumption Value Market Share by Type in 2023
1.3.3 Dukoral
1.3.4 Shanchol
1.3.5 Vaxchora
1.3.6 Others
1.4 Global Cholera Vaccines Market by Application
1.4.1 Overview: Global Cholera Vaccines Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oral
1.4.3 Others
1.5 Global Cholera Vaccines Market Size & Forecast
1.6 Global Cholera Vaccines Market Size and Forecast by Region
1.6.1 Global Cholera Vaccines Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Cholera Vaccines Market Size by Region, (2019-2030)
1.6.3 North America Cholera Vaccines Market Size and Prospect (2019-2030)
1.6.4 Europe Cholera Vaccines Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Cholera Vaccines Market Size and Prospect (2019-2030)
1.6.6 South America Cholera Vaccines Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Cholera Vaccines Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Shantha Biotechnics Private Limited
2.1.1 Shantha Biotechnics Private Limited Details
2.1.2 Shantha Biotechnics Private Limited Major Business
2.1.3 Shantha Biotechnics Private Limited Cholera Vaccines Product and Solutions
2.1.4 Shantha Biotechnics Private Limited Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Shantha Biotechnics Private Limited Recent Developments and Future Plans
2.2 PaxVax, Inc.
2.2.1 PaxVax, Inc. Details
2.2.2 PaxVax, Inc. Major Business
2.2.3 PaxVax, Inc. Cholera Vaccines Product and Solutions
2.2.4 PaxVax, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 PaxVax, Inc. Recent Developments and Future Plans
2.3 Valneva SE
2.3.1 Valneva SE Details
2.3.2 Valneva SE Major Business
2.3.3 Valneva SE Cholera Vaccines Product and Solutions
2.3.4 Valneva SE Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Valneva SE Recent Developments and Future Plans
2.4 Merck and Co., Inc.
2.4.1 Merck and Co., Inc. Details
2.4.2 Merck and Co., Inc. Major Business
2.4.3 Merck and Co., Inc. Cholera Vaccines Product and Solutions
2.4.4 Merck and Co., Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Merck and Co., Inc. Recent Developments and Future Plans
2.5 GlaxoSmithKline plc (GSK)
2.5.1 GlaxoSmithKline plc (GSK) Details
2.5.2 GlaxoSmithKline plc (GSK) Major Business
2.5.3 GlaxoSmithKline plc (GSK) Cholera Vaccines Product and Solutions
2.5.4 GlaxoSmithKline plc (GSK) Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 GlaxoSmithKline plc (GSK) Recent Developments and Future Plans
2.6 Astellas Pharma, Inc.
2.6.1 Astellas Pharma, Inc. Details
2.6.2 Astellas Pharma, Inc. Major Business
2.6.3 Astellas Pharma, Inc. Cholera Vaccines Product and Solutions
2.6.4 Astellas Pharma, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Astellas Pharma, Inc. Recent Developments and Future Plans
2.7 Pfizer, Inc.
2.7.1 Pfizer, Inc. Details
2.7.2 Pfizer, Inc. Major Business
2.7.3 Pfizer, Inc. Cholera Vaccines Product and Solutions
2.7.4 Pfizer, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Pfizer, Inc. Recent Developments and Future Plans
2.8 Emergent BioSolutions, Inc.
2.8.1 Emergent BioSolutions, Inc. Details
2.8.2 Emergent BioSolutions, Inc. Major Business
2.8.3 Emergent BioSolutions, Inc. Cholera Vaccines Product and Solutions
2.8.4 Emergent BioSolutions, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Emergent BioSolutions, Inc. Recent Developments and Future Plans
2.9 Mitsubishi Tanabe Pharma Corporation
2.9.1 Mitsubishi Tanabe Pharma Corporation Details
2.9.2 Mitsubishi Tanabe Pharma Corporation Major Business
2.9.3 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product and Solutions
2.9.4 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Mitsubishi Tanabe Pharma Corporation Recent Developments and Future Plans
2.10 Takeda Pharmaceutical Co., Ltd.
2.10.1 Takeda Pharmaceutical Co., Ltd. Details
2.10.2 Takeda Pharmaceutical Co., Ltd. Major Business
2.10.3 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product and Solutions
2.10.4 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Takeda Pharmaceutical Co., Ltd. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cholera Vaccines Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Cholera Vaccines by Company Revenue
3.2.2 Top 3 Cholera Vaccines Players Market Share in 2023
3.2.3 Top 6 Cholera Vaccines Players Market Share in 2023
3.3 Cholera Vaccines Market: Overall Company Footprint Analysis
3.3.1 Cholera Vaccines Market: Region Footprint
3.3.2 Cholera Vaccines Market: Company Product Type Footprint
3.3.3 Cholera Vaccines Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cholera Vaccines Consumption Value and Market Share by Type (2019-2024)
4.2 Global Cholera Vaccines Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cholera Vaccines Consumption Value Market Share by Application (2019-2024)
5.2 Global Cholera Vaccines Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Cholera Vaccines Consumption Value by Type (2019-2030)
6.2 North America Cholera Vaccines Consumption Value by Application (2019-2030)
6.3 North America Cholera Vaccines Market Size by Country
6.3.1 North America Cholera Vaccines Consumption Value by Country (2019-2030)
6.3.2 United States Cholera Vaccines Market Size and Forecast (2019-2030)
6.3.3 Canada Cholera Vaccines Market Size and Forecast (2019-2030)
6.3.4 Mexico Cholera Vaccines Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Cholera Vaccines Consumption Value by Type (2019-2030)
7.2 Europe Cholera Vaccines Consumption Value by Application (2019-2030)
7.3 Europe Cholera Vaccines Market Size by Country
7.3.1 Europe Cholera Vaccines Consumption Value by Country (2019-2030)
7.3.2 Germany Cholera Vaccines Market Size and Forecast (2019-2030)
7.3.3 France Cholera Vaccines Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Cholera Vaccines Market Size and Forecast (2019-2030)
7.3.5 Russia Cholera Vaccines Market Size and Forecast (2019-2030)
7.3.6 Italy Cholera Vaccines Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cholera Vaccines Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Cholera Vaccines Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Cholera Vaccines Market Size by Region
8.3.1 Asia-Pacific Cholera Vaccines Consumption Value by Region (2019-2030)
8.3.2 China Cholera Vaccines Market Size and Forecast (2019-2030)
8.3.3 Japan Cholera Vaccines Market Size and Forecast (2019-2030)
8.3.4 South Korea Cholera Vaccines Market Size and Forecast (2019-2030)
8.3.5 India Cholera Vaccines Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Cholera Vaccines Market Size and Forecast (2019-2030)
8.3.7 Australia Cholera Vaccines Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Cholera Vaccines Consumption Value by Type (2019-2030)
9.2 South America Cholera Vaccines Consumption Value by Application (2019-2030)
9.3 South America Cholera Vaccines Market Size by Country
9.3.1 South America Cholera Vaccines Consumption Value by Country (2019-2030)
9.3.2 Brazil Cholera Vaccines Market Size and Forecast (2019-2030)
9.3.3 Argentina Cholera Vaccines Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cholera Vaccines Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Cholera Vaccines Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Cholera Vaccines Market Size by Country
10.3.1 Middle East & Africa Cholera Vaccines Consumption Value by Country (2019-2030)
10.3.2 Turkey Cholera Vaccines Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Cholera Vaccines Market Size and Forecast (2019-2030)
10.3.4 UAE Cholera Vaccines Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Cholera Vaccines Market Drivers
11.2 Cholera Vaccines Market Restraints
11.3 Cholera Vaccines Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Cholera Vaccines Industry Chain
12.2 Cholera Vaccines Upstream Analysis
12.3 Cholera Vaccines Midstream Analysis
12.4 Cholera Vaccines Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Cholera Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Cholera Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Cholera Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Cholera Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Shantha Biotechnics Private Limited Company Information, Head Office, and Major Competitors
Table 6. Shantha Biotechnics Private Limited Major Business
Table 7. Shantha Biotechnics Private Limited Cholera Vaccines Product and Solutions
Table 8. Shantha Biotechnics Private Limited Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Shantha Biotechnics Private Limited Recent Developments and Future Plans
Table 10. PaxVax, Inc. Company Information, Head Office, and Major Competitors
Table 11. PaxVax, Inc. Major Business
Table 12. PaxVax, Inc. Cholera Vaccines Product and Solutions
Table 13. PaxVax, Inc. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. PaxVax, Inc. Recent Developments and Future Plans
Table 15. Valneva SE Company Information, Head Office, and Major Competitors
Table 16. Valneva SE Major Business
Table 17. Valneva SE Cholera Vaccines Product and Solutions
Table 18. Valneva SE Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Valneva SE Recent Developments and Future Plans
Table 20. Merck and Co., Inc. Company Information, Head Office, and Major Competitors
Table 21. Merck and Co., Inc. Major Business
Table 22. Merck and Co., Inc. Cholera Vaccines Product and Solutions
Table 23. Merck and Co., Inc. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Merck and Co., Inc. Recent Developments and Future Plans
Table 25. GlaxoSmithKline plc (GSK) Company Information, Head Office, and Major Competitors
Table 26. GlaxoSmithKline plc (GSK) Major Business
Table 27. GlaxoSmithKline plc (GSK) Cholera Vaccines Product and Solutions
Table 28. GlaxoSmithKline plc (GSK) Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. GlaxoSmithKline plc (GSK) Recent Developments and Future Plans
Table 30. Astellas Pharma, Inc. Company Information, Head Office, and Major Competitors
Table 31. Astellas Pharma, Inc. Major Business
Table 32. Astellas Pharma, Inc. Cholera Vaccines Product and Solutions
Table 33. Astellas Pharma, Inc. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Astellas Pharma, Inc. Recent Developments and Future Plans
Table 35. Pfizer, Inc. Company Information, Head Office, and Major Competitors
Table 36. Pfizer, Inc. Major Business
Table 37. Pfizer, Inc. Cholera Vaccines Product and Solutions
Table 38. Pfizer, Inc. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Pfizer, Inc. Recent Developments and Future Plans
Table 40. Emergent BioSolutions, Inc. Company Information, Head Office, and Major Competitors
Table 41. Emergent BioSolutions, Inc. Major Business
Table 42. Emergent BioSolutions, Inc. Cholera Vaccines Product and Solutions
Table 43. Emergent BioSolutions, Inc. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Emergent BioSolutions, Inc. Recent Developments and Future Plans
Table 45. Mitsubishi Tanabe Pharma Corporation Company Information, Head Office, and Major Competitors
Table 46. Mitsubishi Tanabe Pharma Corporation Major Business
Table 47. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product and Solutions
Table 48. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Mitsubishi Tanabe Pharma Corporation Recent Developments and Future Plans
Table 50. Takeda Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 51. Takeda Pharmaceutical Co., Ltd. Major Business
Table 52. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product and Solutions
Table 53. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Takeda Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 55. Global Cholera Vaccines Revenue (USD Million) by Players (2019-2024)
Table 56. Global Cholera Vaccines Revenue Share by Players (2019-2024)
Table 57. Breakdown of Cholera Vaccines by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Cholera Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Cholera Vaccines Players
Table 60. Cholera Vaccines Market: Company Product Type Footprint
Table 61. Cholera Vaccines Market: Company Product Application Footprint
Table 62. Cholera Vaccines New Market Entrants and Barriers to Market Entry
Table 63. Cholera Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Cholera Vaccines Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Cholera Vaccines Consumption Value Share by Type (2019-2024)
Table 66. Global Cholera Vaccines Consumption Value Forecast by Type (2025-2030)
Table 67. Global Cholera Vaccines Consumption Value by Application (2019-2024)
Table 68. Global Cholera Vaccines Consumption Value Forecast by Application (2025-2030)
Table 69. North America Cholera Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Cholera Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Cholera Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Cholera Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Cholera Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Cholera Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Cholera Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Cholera Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Cholera Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Cholera Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Cholera Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Cholera Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Cholera Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Cholera Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Cholera Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Cholera Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Cholera Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Cholera Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Cholera Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Cholera Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Cholera Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Cholera Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Cholera Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Cholera Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Cholera Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Cholera Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Cholera Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Cholera Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Cholera Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Cholera Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Cholera Vaccines Raw Material
Table 100. Key Suppliers of Cholera Vaccines Raw Materials
Table 1. Global Cholera Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Cholera Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Cholera Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Cholera Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Shantha Biotechnics Private Limited Company Information, Head Office, and Major Competitors
Table 6. Shantha Biotechnics Private Limited Major Business
Table 7. Shantha Biotechnics Private Limited Cholera Vaccines Product and Solutions
Table 8. Shantha Biotechnics Private Limited Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Shantha Biotechnics Private Limited Recent Developments and Future Plans
Table 10. PaxVax, Inc. Company Information, Head Office, and Major Competitors
Table 11. PaxVax, Inc. Major Business
Table 12. PaxVax, Inc. Cholera Vaccines Product and Solutions
Table 13. PaxVax, Inc. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. PaxVax, Inc. Recent Developments and Future Plans
Table 15. Valneva SE Company Information, Head Office, and Major Competitors
Table 16. Valneva SE Major Business
Table 17. Valneva SE Cholera Vaccines Product and Solutions
Table 18. Valneva SE Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Valneva SE Recent Developments and Future Plans
Table 20. Merck and Co., Inc. Company Information, Head Office, and Major Competitors
Table 21. Merck and Co., Inc. Major Business
Table 22. Merck and Co., Inc. Cholera Vaccines Product and Solutions
Table 23. Merck and Co., Inc. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Merck and Co., Inc. Recent Developments and Future Plans
Table 25. GlaxoSmithKline plc (GSK) Company Information, Head Office, and Major Competitors
Table 26. GlaxoSmithKline plc (GSK) Major Business
Table 27. GlaxoSmithKline plc (GSK) Cholera Vaccines Product and Solutions
Table 28. GlaxoSmithKline plc (GSK) Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. GlaxoSmithKline plc (GSK) Recent Developments and Future Plans
Table 30. Astellas Pharma, Inc. Company Information, Head Office, and Major Competitors
Table 31. Astellas Pharma, Inc. Major Business
Table 32. Astellas Pharma, Inc. Cholera Vaccines Product and Solutions
Table 33. Astellas Pharma, Inc. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Astellas Pharma, Inc. Recent Developments and Future Plans
Table 35. Pfizer, Inc. Company Information, Head Office, and Major Competitors
Table 36. Pfizer, Inc. Major Business
Table 37. Pfizer, Inc. Cholera Vaccines Product and Solutions
Table 38. Pfizer, Inc. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Pfizer, Inc. Recent Developments and Future Plans
Table 40. Emergent BioSolutions, Inc. Company Information, Head Office, and Major Competitors
Table 41. Emergent BioSolutions, Inc. Major Business
Table 42. Emergent BioSolutions, Inc. Cholera Vaccines Product and Solutions
Table 43. Emergent BioSolutions, Inc. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Emergent BioSolutions, Inc. Recent Developments and Future Plans
Table 45. Mitsubishi Tanabe Pharma Corporation Company Information, Head Office, and Major Competitors
Table 46. Mitsubishi Tanabe Pharma Corporation Major Business
Table 47. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product and Solutions
Table 48. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Mitsubishi Tanabe Pharma Corporation Recent Developments and Future Plans
Table 50. Takeda Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 51. Takeda Pharmaceutical Co., Ltd. Major Business
Table 52. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product and Solutions
Table 53. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Takeda Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 55. Global Cholera Vaccines Revenue (USD Million) by Players (2019-2024)
Table 56. Global Cholera Vaccines Revenue Share by Players (2019-2024)
Table 57. Breakdown of Cholera Vaccines by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Cholera Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Cholera Vaccines Players
Table 60. Cholera Vaccines Market: Company Product Type Footprint
Table 61. Cholera Vaccines Market: Company Product Application Footprint
Table 62. Cholera Vaccines New Market Entrants and Barriers to Market Entry
Table 63. Cholera Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Cholera Vaccines Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Cholera Vaccines Consumption Value Share by Type (2019-2024)
Table 66. Global Cholera Vaccines Consumption Value Forecast by Type (2025-2030)
Table 67. Global Cholera Vaccines Consumption Value by Application (2019-2024)
Table 68. Global Cholera Vaccines Consumption Value Forecast by Application (2025-2030)
Table 69. North America Cholera Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Cholera Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Cholera Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Cholera Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Cholera Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Cholera Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Cholera Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Cholera Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Cholera Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Cholera Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Cholera Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Cholera Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Cholera Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Cholera Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Cholera Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Cholera Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Cholera Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Cholera Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Cholera Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Cholera Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Cholera Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Cholera Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Cholera Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Cholera Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Cholera Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Cholera Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Cholera Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Cholera Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Cholera Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Cholera Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Cholera Vaccines Raw Material
Table 100. Key Suppliers of Cholera Vaccines Raw Materials
LIST OF FIGURES
Figure 1. Cholera Vaccines Picture
Figure 2. Global Cholera Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Cholera Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Dukoral
Figure 5. Shanchol
Figure 6. Vaxchora
Figure 7. Others
Figure 8. Global Cholera Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Cholera Vaccines Consumption Value Market Share by Application in 2023
Figure 10. Oral Picture
Figure 11. Others Picture
Figure 12. Global Cholera Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Cholera Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Cholera Vaccines Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Cholera Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Cholera Vaccines Consumption Value Market Share by Region in 2023
Figure 17. North America Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Cholera Vaccines Revenue Share by Players in 2023
Figure 23. Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Cholera Vaccines Market Share in 2023
Figure 25. Global Top 6 Players Cholera Vaccines Market Share in 2023
Figure 26. Global Cholera Vaccines Consumption Value Share by Type (2019-2024)
Figure 27. Global Cholera Vaccines Market Share Forecast by Type (2025-2030)
Figure 28. Global Cholera Vaccines Consumption Value Share by Application (2019-2024)
Figure 29. Global Cholera Vaccines Market Share Forecast by Application (2025-2030)
Figure 30. North America Cholera Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Cholera Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Cholera Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Cholera Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Cholera Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Cholera Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 40. France Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Cholera Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Cholera Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Cholera Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 47. China Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 50. India Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Cholera Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Cholera Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Cholera Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Cholera Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Cholera Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Cholera Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 64. Cholera Vaccines Market Drivers
Figure 65. Cholera Vaccines Market Restraints
Figure 66. Cholera Vaccines Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Cholera Vaccines in 2023
Figure 69. Manufacturing Process Analysis of Cholera Vaccines
Figure 70. Cholera Vaccines Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Cholera Vaccines Picture
Figure 2. Global Cholera Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Cholera Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Dukoral
Figure 5. Shanchol
Figure 6. Vaxchora
Figure 7. Others
Figure 8. Global Cholera Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Cholera Vaccines Consumption Value Market Share by Application in 2023
Figure 10. Oral Picture
Figure 11. Others Picture
Figure 12. Global Cholera Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Cholera Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Cholera Vaccines Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Cholera Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Cholera Vaccines Consumption Value Market Share by Region in 2023
Figure 17. North America Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Cholera Vaccines Revenue Share by Players in 2023
Figure 23. Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Cholera Vaccines Market Share in 2023
Figure 25. Global Top 6 Players Cholera Vaccines Market Share in 2023
Figure 26. Global Cholera Vaccines Consumption Value Share by Type (2019-2024)
Figure 27. Global Cholera Vaccines Market Share Forecast by Type (2025-2030)
Figure 28. Global Cholera Vaccines Consumption Value Share by Application (2019-2024)
Figure 29. Global Cholera Vaccines Market Share Forecast by Application (2025-2030)
Figure 30. North America Cholera Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Cholera Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Cholera Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Cholera Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Cholera Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Cholera Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 40. France Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Cholera Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Cholera Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Cholera Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 47. China Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 50. India Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Cholera Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Cholera Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Cholera Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Cholera Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Cholera Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Cholera Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Cholera Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 64. Cholera Vaccines Market Drivers
Figure 65. Cholera Vaccines Market Restraints
Figure 66. Cholera Vaccines Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Cholera Vaccines in 2023
Figure 69. Manufacturing Process Analysis of Cholera Vaccines
Figure 70. Cholera Vaccines Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
